Ignite Creation Date:
2024-05-06 @ 12:06 AM
Last Modification Date:
2024-10-26 @ 10:44 AM
Study NCT ID:
NCT01483144
Status:
COMPLETED
Last Update Posted:
2021-06-08
First Post:
2011-11-21
Brief Title:
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis FAP
Sponsor:
Cancer Prevention Pharmaceuticals Inc
Organization:
Cancer Prevention Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2018-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-21
First Submit QC Date:
November 30 2011
Study First Post Date:
2011-12-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-06-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2020-01-28
Disp First Submit QC Date:
January 28 2020
Disp First Post Date:
2020-02-07
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-05-12
Last Update Post Date:
2021-06-08
Last Update Post Date Type:
ACTUAL